Anodic oxidized nanotubular titanium implants enhance bone morphogenetic protein-2 delivery

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 93, Issue 2, 2010, Pages 484-491

  Bae, In Ho ^a   Yun, Kwi Dug ^a   Kim, Hyun Seung ^b   Jeong, Byung Chul ^a   Lim, Hyun Pil ^a   Park, Sang Won ^a   Lee, Kwang Min ^a   Lim, Young Chai ^a   Lee, Kyung Ku ^c   Yang, Yunzhi ^a,d   Koh, Jeong Tae ^a  

^a Chonnam National University   (South Korea)

^b MegaGen Co Ltd   (South Korea)

^c Chonnam National University   (South Korea)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Anodic oxidation; Bone morphogenetic protein 2 delivery; Nanotube; Osseointegration; Osteoblast differentiation; Titanium implant

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEIN-2 DELIVERY; OSSEOINTEGRATION; OSTEOBLAST DIFFERENTIATION; TITANIUM IMPLANT; TITANIUM IMPLANTS;

ANGLE MEASUREMENT; BONE; CALCIUM; CONTACT ANGLE; NANOTUBES; PHOSPHATASES; PROTEINS; SCANNING ELECTRON MICROSCOPY; TITANIUM;

ANODIC OXIDATION;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; NANOTUBE; TITANIUM; TITANIUM DIOXIDE;

ADSORPTION; ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; CONTACT ANGLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYDROPHILICITY; IMPLANT; MORPHOLOGY; MOUSE; NONHUMAN; OXIDATION; SCANNING ELECTRON MICROSCOPY; VELOCITY;

ADSORPTION; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL LINE; DRUG DELIVERY SYSTEMS; HUMANS; IMPLANTS, EXPERIMENTAL; MICE; NANOTUBES; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SURFACE PROPERTIES; TITANIUM;

EID: 77951186823     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31606     Document Type: Article

References (32)

1. Pohler OE. Unalloyed titanium for implants in bone surgery. Injury 2000;31 (Suppl 4):7-13.
2. Yang Y, Oh N, Liu Y, Chen W, Oh S, Appleford M, Kim S, Kim K, Park S, Bumgardner J, Haggard W, Ong J. Enhancement of osseointegration using surface modified titanium implants. J Miner Met Mater 2006;58:71-76.
3. Sul YT, Johansson CB, Petronis S, Krozer A, Jeong Y, Wennerberg A, Albrektsson T. Characteristics of the surface oxides on turned and electrochemically oxidized pure titanium implants up to dielectric breakdown: The oxide thickness, micropore configurations, surface roughness, crystal structure and chemical composition. Biomaterials 2002;23:491-501.
4. Liu Y, Park S, Kim H, Lee K, Koh J, Nishimoto SK, Bumgardner J, Haggard W, Yang Y. Engineered Titanium Surface Promoting Osseointegration. Ahmed W, Ali N, Oechsner A, editor. Biomaterials and Biomedical Engineering 2008, 115-134.
5. Nishimoto SK, Nishimoto M, Park SW, Lee KM, Kim HS, Koh JT, Ong JL, Liu Y, Yang Y. The effect of titanium surface roughening on protein absorption, cell attachment, and cell spreading. Int J Oral Maxillofac Implants 2008;23:675-680.
6. Frauchiger VM, Schlottig F, Gasser B, Textor M. Anodic plasmachemical treatment of CP titanium surfaces for biomedical applications. Biomaterials 2004;25:593-606.
7. Fini M, Cigada A, Rondelli G, Chiesa R, Giardino R, Giavaresi G, Nicoli Aldini N, Torricelli P, Vicentini B. In vitro and in vivo behaviour of Ca- and P-enriched anodized titanium. Biomaterials 1999; 20:1587-1594.
8. Yang Y, Kim KH, Ong JL. A review on calcium phosphate coatings produced using a sputtering process - An alternative to plasma spraying. Biomaterials 2005;26:327-337.
9. Wong M, Eulenberger J, Schenk R, Hunziker E. Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res 1995;29:1567-1575.
10. Gottlander M, Albrektsson T. Histomorphometric studies of hydroxylapatite-coated and uncoated CP titanium threaded implants in bone. Int J Oral Maxillofac Implants 1991;6:399-404.
11. Kim HS, Yang Y, Koh JT, Lee KK, Lee DJ, Lee KM, Park SW. Fabrication and characterization of functionally graded nano-micro porous titanium surface by anodizing. J Biomed Mater Res B: Appl Biomater 2009;88:427-435.
12. Schreckenbach JP, Marx G, Schlottig F, Textor M, Spencer ND. Characterization of anodic spark-converted titanium surfaces for biomedical applications. J Mater Sci: Mater Med 1999;10:453-457.
13. Sul YT, Johansson CB, Roser K, Albrektsson T. Qualitative and quantitative observations of bone tissue reactions to anodised implants. Biomaterials 2002;23:1809-1817.
14. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-9847.
15. Wang EA. Bone morphogenetic proteins (BMPs): Therapeutic potential in healing bony defects. Trends Biotechnol 1993;11:379-383.
16. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990;9:2085-2093.
17. Sampath TK, Coughlin JE, Whetstone RM, Banach D, Corbett C, Ridge RJ, Ozkaynak E, Oppermann H, Rueger DC. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 1990;265:13198-13205.
18. Ozkaynak E, Schnegelsberg PN, Jin DF, Clifford GM, Warren FD, Drier EA, Oppermann H. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J Biol Chem 1992;267:25220-25227.
19. Elima K. Osteoinductive proteins. Ann Med 1993;25:395-402.
20. Rosen V, Thies RS. The BMP proteins in bone formation and repair. Trends Genet 1992;8:97-102.
21. Reddi AH, Cunningham NS. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 1993;8 (Suppl 2):S499-S502.
22. Bessho K, Carnes DL, Cavin R, Chen HY, Ong JL. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin Oral Implants Res 1999;10:212-218.
23. Stenport VF, Roos-Jansaker AM, Renvert S, Kuboki Y, Irwin C, Albrektsson T, Claffey N. Failure to induce supracrestal bone growth between and around partially inserted titanium implants using bone morphogenetic protein (BMP): An experimental study in dogs. Clin Oral Implants Res 2003;14:219-225.
24. Puleo DA, Huh WW, Duggirala SS, DeLuca PP. In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2. J Biomed Mater Res 1998; 41:104-110.
25. Puleo DA. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J Cell Physiol 1997;173:93-101.
26. Sawase T, Jimbo R, Wennerberg A, Suketa N, Tanaka Y, Atsuta M. A novel characteristic of porous titanium oxide implants. Clin Oral Implants Res 2007;18:680-685.
27. Foraker AB, Walczak RJ, Cohen MH, Boiarski TA, Grove CF, Swaan PW. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm Res 2003;20:110-116.
28. Salonen J, Laitinen L, Kaukonen AM, Tuura J, Bjorkqvist M, Heikkila T, Vaha-Heikkila K, Hirvonen J, Lehto VP. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J Control Release 2005;108:362-374.
29. Manolagas SC, Burton DW, Deftos LJ. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 1981;256:7115-7117.
30. Mor GK, Varhese OK, Paulose M, Mukherjee N, Grimes CA. Fabrication of tapered, conical-shaped titania nanotubes. J Mater Res 2003;18:3331-3334.
31. Kakoli D, Susmita B, Amit B. Surface modifications and cellmaterials interactions with anodized Ti. Acta Biomater 2007;3:573-585.
32. Webb K, Hlady V, Tresco PA. Relative importance of surface wettability and charged functional groups on NIH 3T3 fibroblast attachment, spreading, and cytoskeletal organization. J Biomed Mater Res 1998;41:422-430.